| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Iara Carolina Barbosa Henrique, Tácio de Mendonça Lima, Daniela Oliveira de Melo, Patricia Melo Aguia. Economic evaluations on the use of aripiprazole for patients with schizophrenia: A systematic review. Journal of clinical pharmacy and therapeutics. vol 45. issue 1. 2020-10-07. PMID:31436857. |
this study evaluates and summarizes the evidence of economic evaluations of the use of aripiprazole in schizophrenia. |
2020-10-07 |
2023-08-13 |
Not clear |
| Christophe Sapin, Ann Hartry, Siddhesh A Kamat, Maud Beillat, Ross A Baker, Anna Eram. Pharmacoeconomic comparison of aripiprazole once-monthly and paliperidone palmitate from a head-to-head clinical trial in schizophrenia: a US analysis. Drugs in context. vol 5. 2020-10-01. PMID:27708677. |
pharmacoeconomic comparison of aripiprazole once-monthly and paliperidone palmitate from a head-to-head clinical trial in schizophrenia: a us analysis. |
2020-10-01 |
2023-08-13 |
Not clear |
| Christophe Sapin, Ann Hartry, Siddhesh A Kamat, Maud Beillat, Ross A Baker, Anna Eram. Pharmacoeconomic comparison of aripiprazole once-monthly and paliperidone palmitate from a head-to-head clinical trial in schizophrenia: a US analysis. Drugs in context. vol 5. 2020-10-01. PMID:27708677. |
in quality of life with abilify maintena (qualify), a randomized head-to-head study of aripiprazole once-monthly 400 mg (aom 400) compared with paliperidone palmitate (pp; 78-234 mg/mo), aom 400 demonstrated greater improvement in health-related quality of life and functioning in patients with stable schizophrenia. |
2020-10-01 |
2023-08-13 |
Not clear |
| Timothy Peters-Strickland, Linda Pestreich, Ainslie Hatch, Shashank Rohatagi, Ross A Baker, John P Docherty, Lada Markovtsova, Praveen Raja, Peter J Weiden, David P Wallin. Usability of a novel digital medicine system in adults with schizophrenia treated with sensor-embedded tablets of aripiprazole. Neuropsychiatric disease and treatment. vol 12. 2020-10-01. PMID:27785036. |
usability of a novel digital medicine system in adults with schizophrenia treated with sensor-embedded tablets of aripiprazole. |
2020-10-01 |
2023-08-13 |
Not clear |
| Timothy Peters-Strickland, Linda Pestreich, Ainslie Hatch, Shashank Rohatagi, Ross A Baker, John P Docherty, Lada Markovtsova, Praveen Raja, Peter J Weiden, David P Wallin. Usability of a novel digital medicine system in adults with schizophrenia treated with sensor-embedded tablets of aripiprazole. Neuropsychiatric disease and treatment. vol 12. 2020-10-01. PMID:27785036. |
this study evaluated usability of the dms in adults with schizophrenia rated by both patients and their health care providers (hcps) during 8-week treatment with prescribed doses of digital aripiprazole. |
2020-10-01 |
2023-08-13 |
Not clear |
| Britta Galling, Alexandra Roldán, Katsuhiko Hagi, Liz Rietschel, Frozan Walyzada, Wei Zheng, Xiao-Lan Cao, Yu-Tao Xiang, Mathias Zink, John M Kane, Jimmi Nielsen, Stefan Leucht, Christoph U Correl. Antipsychotic augmentation vs. monotherapy in schizophrenia: systematic review, meta-analysis and meta-regression analysis. World psychiatry : official journal of the World Psychiatric Association (WPA). vol 16. issue 1. 2020-10-01. PMID:28127934. |
these data suggest that the common practice of antipsychotic augmentation in schizophrenia lacks double-blind/high-quality evidence for efficacy, except for negative symptom reduction with aripiprazole augmentation. |
2020-10-01 |
2023-08-13 |
Not clear |
| Phyllis M Salzman, Arash Raoufinia, Susan Legacy, Pedro Such, Anna Eram. Plasma concentrations and dosing of 2 long-acting injectable formulations of aripiprazole. Neuropsychiatric disease and treatment. vol 13. 2020-10-01. PMID:28461748. |
aripiprazole is an atypical antipsychotic used in the treatment of schizophrenia and is available in 2 chemically different (aripiprazole monohydrate and aripiprazole lauroxil [al]) and pharmaceutically different lai formulations (aripiprazole once-monthly 400 mg [aom 400] and al). |
2020-10-01 |
2023-08-13 |
Not clear |
| Hidenobu Suzuki, Hiroyuki Hibino, Yuichi Inoue, Hideo Matsumoto, Katsunaka Mikam. The effect of switching from oral low-dose aripiprazole to aripiprazole once-monthly 300 mg on the quality of life in three patients with schizophrenia. SAGE open medical case reports. vol 5. 2020-10-01. PMID:28596830. |
the effect of switching from oral low-dose aripiprazole to aripiprazole once-monthly 300 mg on the quality of life in three patients with schizophrenia. |
2020-10-01 |
2023-08-13 |
Not clear |
| Corrigendum: Pharmacoeconomic comparison of aripiprazole once-monthly and paliperidone palmitate from a head-to-head clinical trial in schizophrenia: a US analysis. Drugs in context. vol 6. 2020-10-01. PMID:28706556. |
corrigendum: pharmacoeconomic comparison of aripiprazole once-monthly and paliperidone palmitate from a head-to-head clinical trial in schizophrenia: a us analysis. |
2020-10-01 |
2023-08-13 |
Not clear |
| Eiji Kirin. Serum prolactin levels and sexual dysfunction in patients with schizophrenia treated with antipsychotics: comparison between aripiprazole and other atypical antipsychotics. Annals of general psychiatry. vol 16. 2020-10-01. PMID:29209406. |
serum prolactin levels and sexual dysfunction in patients with schizophrenia treated with antipsychotics: comparison between aripiprazole and other atypical antipsychotics. |
2020-10-01 |
2023-08-13 |
Not clear |
| Yuki Omori, Takashi Kanbayashi, Yohei Sagawa, Aya Imanishi, Ko Tsutsui, Yuya Takahashi, Masahiro Takeshima, Manabu Takaki, Seiji Nishino, Tetsuo Shimiz. Low dose of aripiprazole advanced sleep rhythm and reduced nocturnal sleep time in the patients with delayed sleep phase syndrome: an open-labeled clinical observation. Neuropsychiatric disease and treatment. vol 14. 2020-10-01. PMID:29849459. |
aripiprazole (apz), a second-generation antipsychotic, is effective in treatment of depression as well as schizophrenia. |
2020-10-01 |
2023-08-13 |
human |
| Jeong Ha Park, Ji Son Hong, Sun Mi Kim, Kyung Joon Min, Un Sun Chung, Doug Hyun Ha. Effects of Amisulpride Adjunctive Therapy on Working Memory and Brain Metabolism in the Frontal Cortex of Patients with Schizophrenia: A Preliminary Positron Emission Tomography/Computerized Tomography Investigation. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology. vol 17. issue 2. 2020-10-01. PMID:30905125. |
we hypothesized that patients with schizophrenia treated with amisulpride and aripiprazole show increased working memory and glucose metabolism compared with those treated with cognitive behavioral therapy (cbt) and aripiprazole instead. |
2020-10-01 |
2023-08-13 |
Not clear |
| Marjie L Hard, Angela Wehr, Lisa von Moltke, Yangchun Du, Sarah Farwick, David P Walling, John Sonnenber. Pharmacokinetics and safety of deltoid or gluteal injection of aripiprazole lauroxil NanoCrystal Therapeutic advances in psychopharmacology. vol 9. 2020-10-01. PMID:31308935. |
pharmacokinetics and safety of deltoid or gluteal injection of aripiprazole lauroxil nanocrystal aripiprazole lauroxil (al), a long-acting injectable antipsychotic for the treatment of schizophrenia in adults, can be started with either 21 days of daily oral aripiprazole supplementation or a 1-day initiation regimen consisting of a single injection of a nanocrystal |
2020-10-01 |
2023-08-13 |
Not clear |
| Wei Zheng, Dong-Bin Cai, Xin-Hu Yang, Gabor S Ungvari, Chee H Ng, Zhan-Ming Shi, Mei-Ling Hu, Yu-Ping Ning, Yu-Tao Xian. Adjunctive aripiprazole for antipsychotic-related hyperprolactinaemia in patients with first-episode schizophrenia: a meta-analysis. General psychiatry. vol 32. issue 5. 2020-10-01. PMID:31673677. |
adjunctive aripiprazole for antipsychotic-related hyperprolactinaemia in patients with first-episode schizophrenia: a meta-analysis. |
2020-10-01 |
2023-08-13 |
Not clear |
| Dahlia Rosally Turangan, Bahagia Loebis, Surya M Husada, Nazli Mahdinasari Nasutio. Differences of Fasting Blood Glucose Level in People with Schizophrenia between Before and After Getting Aripiprazole Treatment. Open access Macedonian journal of medical sciences. vol 7. issue 16. 2020-10-01. PMID:31777615. |
differences of fasting blood glucose level in people with schizophrenia between before and after getting aripiprazole treatment. |
2020-10-01 |
2023-08-13 |
Not clear |
| Andreas Schreiner, Paul Bergmans, Pierre Cherubin, Ludger Hargarte. The effect of long-acting paliperidone palmitate once-monthly on negative and depressive symptoms in patients with schizophrenia switched from previous unsuccessful treatment with oral aripiprazole. Therapeutic advances in psychopharmacology. vol 7. issue 2. 2020-09-30. PMID:28255435. |
the effect of long-acting paliperidone palmitate once-monthly on negative and depressive symptoms in patients with schizophrenia switched from previous unsuccessful treatment with oral aripiprazole. |
2020-09-30 |
2023-08-13 |
Not clear |
| Katsumasa Muneoka, Nobuhisa Kanahara, Shou Kimur. Switching to aripiprazole for the treatment of residual mutism resulted in distinct clinical courses in two catatonic schizophrenia cases. SAGE open medical case reports. vol 5. 2020-09-30. PMID:28255444. |
switching to aripiprazole for the treatment of residual mutism resulted in distinct clinical courses in two catatonic schizophrenia cases. |
2020-09-30 |
2023-08-13 |
Not clear |
| Santanu Nath, Sajjadur Rehman, Kamal Narayan Kalita, Aparajeeta Barua. Aripiprazole-induced skin rash. Industrial psychiatry journal. vol 25. issue 2. 2020-09-30. PMID:28659705. |
we report a case of skin rash that developed after starting aripiprazole in a male patient suffering from schizophrenia and which remitted after the drug was stopped. |
2020-09-30 |
2023-08-13 |
Not clear |
| Keiki Sakurama, Akito Kawai, Victor Tuan Giam Chuang, Yoko Kanamori, Miyu Osa, Kazuaki Taguchi, Hakaru Seo, Toru Maruyama, Shuhei Imoto, Keishi Yamasaki, Masaki Otagir. Analysis of the Binding of Aripiprazole to Human Serum Albumin: The Importance of a Chloro-Group in the Chemical Structure. ACS omega. vol 3. issue 10. 2020-09-30. PMID:30411049. |
aripiprazole (arp), a quinolinone derivative, is an atypical antipsychotic drug that is used in the treatment of schizophrenia. |
2020-09-30 |
2023-08-13 |
human |
| Rosaria Di Lorenzo, Paola Ferri, Michela Cameli, Sergio Rovesti, Chiara Piemont. Effectiveness of 1-year treatment with long-acting formulation of aripiprazole, haloperidol, or paliperidone in patients with schizophrenia: retrospective study in a real-world clinical setting. Neuropsychiatric disease and treatment. vol 15. 2020-09-30. PMID:30662264. |
effectiveness of 1-year treatment with long-acting formulation of aripiprazole, haloperidol, or paliperidone in patients with schizophrenia: retrospective study in a real-world clinical setting. |
2020-09-30 |
2023-08-13 |
Not clear |